Tag: kidney disease and diabetes drugs

Chronic Kidney Disease and Metformin or SGLT2 Inhibitors: Dosing and Safety Guidelines 2025

Posted by: Alan Burity Vitulo in: Health and Medicine

12 Dec | 13:41 PM | 0

Updated 2025 guidelines on using metformin and SGLT2 inhibitors safely in chronic kidney disease. Learn correct eGFR dosing thresholds, safety risks, combination therapy benefits, and what to do if your kidney function declines.

How Drug Shortages Are Delaying Treatment and Endangering Patients

Drug shortages are delaying critical treatments, increasing medical errors, and forcing patients to skip doses. Learn how this crisis impacts care, who’s most at risk, and what you can do.

Adolescents and Psychiatric Medications: How to Monitor for Suicidal Ideation

Adolescents on psychiatric medications need close monitoring for suicidal ideation, especially in the first weeks of treatment. Learn the warning signs, best practices, and how families and providers can work together to keep teens safe.

How the FDA Monitors Generic Drug Safety After Approval

The FDA monitors generic drug safety after approval using real-world data, adverse event reports, and market analysis to catch manufacturing defects and therapeutic issues. Learn how the system works - and where it still has gaps.

Most prescriptions are generics-but some medications need to stay brand-name only. Learn when doctors prescribe brand drugs for safety reasons, why generics aren't always interchangeable, and how to protect yourself from unnecessary costs.

Tag: kidney disease and diabetes drugs

Chronic Kidney Disease and Metformin or SGLT2 Inhibitors: Dosing and Safety Guidelines 2025

recent posts

categories

archives

tags